ArticleCase reports in oncology
A Rare Presentation of Palpable Bilateral Male Breast Cancer: A Case Report.
Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: We present a case on bilateral invasive ductal carcinoma in a male patient who presented with two palpable masses with one side initially attributed to gynecomastia. Case Presentation: The patient underwent left breast lumpectomy and sentinel lymph node biopsy and right breast excisional biopsy. Postoperatively, pathology confirmed bilateral invasive carcinoma with one out of eight positive lymph nodes in the left breast. This patient did not undergo further procedures and was established with medical and radiation oncologists. After discussion with the patient and multidisciplinary team, it was decided that chemotherapy and radiation would not benefit this patient. The patient is following up regularly in 3 months postoperatively followed by 6-month intervals and is taking tamoxifen to aid in prevention of recurrence. Conclusion: The presentation of this case contributes to current breast cancer treatment and diagnosis, particularly in subset male population with an atypical presentation and unexpected diagnosis involving both breasts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.